SUPPLY CHAIN DISRUPTION AND SUSTAINABILITY OF PHARMACEUTICAL FIRMS IN ANAMBRA STATE, NIGERIA
DOI:
https://doi.org/10.19166/ms.v4i2.8643Λέξεις-κλειδιά:
Supply Chain Disruption, Pharmaceutical Industry, Sustainability, Anambra State, NigeriaΠερίληψη
The pharmaceutical sector, in Nigeria plays a role in the nations’ healthcare system by supplying medications to the people. However pharmaceutical companies in the Anambra State have been facing obstacles recently due to disruptions in their supply chains. This research investigates how supply chain disruptions impact the sustainability of firms in Anambra State. A mixed-methods approach, involving qualitative interviews with industry experts and quantitative analysis of operational data, identifies the main causes of supply chain disruptions and their effects on this firm’s long-term success. The research reveals that supply chain disruptions result from factors such as delays in customs clearance, inconsistent regulatory policies, currency fluctuations, inadequate transportation infrastructure and issues with supplier reliability. Interviews with industry experts highlighted customs delays as a disruption while quantitative analysis showed a 20% increase in times for imported pharmaceuticals along with a 15% rise in delivery delays and a 10% increase in product returns due to transportation challenges. Moreover, inefficiencies in inventory management were observed, leading to a 5% rise in holding costs and a 3% decrease in turnover rates due to supply chains. Challenges related to suppliers involved issues, with delivery reliability and product quality leading to a 10% extension in supplier lead times and a 5% uptick, in returns. The findings highlighted a direct correlation between these supply chain issues and decreased profitability, operational efficiency, and the ability to meet patient needs, emphasizing the urgent need for improvements to enhance the resilience of the pharmaceutical supply chain in Anambra State.
Αναφορές
Amadi C., & Tsui E. K. (2019). How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria. Research in Social and Administration Pharmcy, 15(11), 1344-1357. https://doi.org/10.1016/j.sapharm.2018.11.011
Asif, K. (2022). The impact of procurement strategies on supply chain sustainability in the pharmaceutical industry. South Asian Journal of Social Review, 1(1), 53-64. https://doi.org/10.57044/SAJSR.2022.1.1.2203
Atadoga, A., Osasoma, F., Amoo, O. O., Farayola, O. A., Ayinla, B. S., & Abrahams, T. O. (2024). The Role of IT in enhancing supply chain resilience: A global review. International Journal of Management & Entrepreneurship Research, 6(2), 336-351. http://dx.doi.org/10.51594/ijmer.v6i2.774
Bahadori, M., Teymourzadeh, E., Bahariniya, S., Tahernezhad, A., & Poorheidari, G. (2024). Factors affecting the pharmaceutical supply chain: A systemic review. Health Scope, 13(2), 1-9. https://doi.org/10.5812/healthscope-140816
Durugbo, C. M. & Al-Balushi, Z. (2022). Supply chain management in times of crisis: A systematic review. Management Review Quarterly, 73, 1179-1235. https://doi.org/10.1007/s11301-022-00272-x
Kanike, U. K. (2023). Factors disrupting supply chain management in manufacturing industries. Journal of Supply chain Management Science, 4(1-2) 1-24. http://dx.doi.org/10.18757/jscms.2023.6986
Moosivand, A., Ghatari, A. R., & Rasekh, H. R. (2017). Supply chain challenges in pharmaceutical manufacturing companies: Using qualitative system dynamics methodology. Iranian Journal of Pharmaceutical Research, 18(2), 1103-1116. https://doi.org/10.22037/ijpr.2019.2389
Olaniran, A., Brigs, J., Pradhan, A., Bogue, E., Schreiber, B., Din, H. S., Hurkchand, H., & Ballard, M. (2022). Stock-outs of essential medicines among community health workers (CHWs) in low- and middle-income countries (LMICs): A systematic literature review of the extent, reasons, and consequences. Human Resources for Health, 20(58), 1--10 https://doi.org/10.1186/s12960-022-00755-8
Omaliko, E. L., Amnim, A., Okeke, P. C., & C., F. (2021). Impact of Covid-19 pandemic on liquidity and profitability of firms in Nigeria. International Journal of Academic Research in Business and Social Sciences, 11(3), 1331-1344. http://dx.doi.org/10.6007/IJARBSS/v11-i3/9229
Paul, S., Kabir, G., Ali, S. M., Zhang, G. (2020). Examining transportation disruption risk in supply chains: A case study from Bangladeshi pharmaceutical industry. Research in Transportation Business & Management, 37, 100-485. https://doi.org/10.1016/j.rtbm.2020.100485
Takawira, B., & Pooe, R. I. D. (2024). Supply chain disruptions during COVID-19 pandemic: Key lessons from the pharmaceutical industry. South African Journal of Business Management, 55(1),1-10. https://doi.org/10.4102/sajbm.v55i1.4048
Zabolotnyy, S., & Wasilewski, M. (2019). The concept of financial sustainability measurement: A case of food companies from Northern Europe. Sustainability, 11(18), 1-16. https://doi.org/10.3390/su11185139
Λήψεις
Δημοσιευμένα
Τεύχος
Ενότητα
Άδεια
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.